Skip to main content
SpringerLink
Log in

Clinical Studies

Reply to Qiao et al.

  • Correspondence
  • Published:
British Journal of Cancer Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Qiao L, Liu Y, Yang Q. Comment on: “Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial”. Br J Cancer. 2024. https://doi.org/10.1038/s41416-024-02690-y

  2. Cai J, Lin K, Luo T, Weng J, Liu H, Yuan Z, et al. Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial. Br J Cancer. 2024. https://doi.org/10.1038/s41416-024-02652-4

  3. Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L, et al. Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol. 2019;37:3223–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Zibin Chen, Kaixin Lin & Huichuan Yu

  2. Guangdong Institute of Gastroenterology, Guangzhou, Guangdong, China

    Zibin Chen, Kaixin Lin & Huichuan Yu

  3. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Zibin Chen, Kaixin Lin & Huichuan Yu

  4. Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, China

    Zibin Chen, Kaixin Lin & Huichuan Yu

  5. Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, Guangzhou, Guangdong, China

    Zibin Chen, Kaixin Lin & Huichuan Yu

  6. Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China

    Zibin Chen

Authors
  1. Zibin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaixin Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huichuan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zibin Chen drafted the manuscript, Kaixin Lin provided methodological support, and Huichuan Yu revised the manuscript.

Corresponding author

Correspondence to Huichuan Yu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Z., Lin, K. & Yu, H. Reply to Qiao et al.. Br J Cancer 130, 1889 (2024). https://doi.org/10.1038/s41416-024-02716-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-024-02716-5

  • Springer Nature Limited

Search

Navigation